Cetera Advisors LLC Selecta Biosciences Inc Transaction History

Cetera Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$3.36 - $4.62 $3.72 Million - $5.11 Million	-1,106,325 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.82 - $5.01 $2.01 Million - $3.58 Million	713,614 Added 181.71%	1,106,325 $4.62 Million
Q1 2021 May 17, 2021	BUY	$2.92 - $5.07 $460,516 - $799,594	157,711 Added 67.11%	392,711 $1.78 Million
Q4 2020 Feb 17, 2021	BUY	$1.64 - $3.42 $385,400 - $803,700	235,000 New	235,000 $712,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.